Clinical Trials Browser

INDUSTRY × racotumomab × CNS × Clear all

NCT02998983 2023-09-11

Racotumomab in Patients With High-risk Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Phase 1 Completed

CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing